The largest database of trusted experimental protocols

3 protocols using anti il10 percp cy5

1

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To exclude dead cells, the cultured Lin cells were stained with a viable fluorescent reactive dye (Invitrogen, Waltham, MA, USA). Additionally, the cells were stained with anti-human hematopoietic lineage antibody cocktail (eBioscience, San Diego, CA, USA), anti-CD45- allophycocyanin (APC, BioLegend), anti-CD294 (CRTH2)-phycoerythrin (PE, Invitrogen), anti-CD127-PE-cy7 (Biolegend), and anti-CTLA4-APC-Cy7 (Invitrogen). For intracellular cytokine staining, Lin cells were stimulated with 50 ng/mL of PMA (Sigma-Aldrich), 1 μg/mL of ionomycin (Sigma-Aldrich), and 1 μg/mL of brefeldin A (Invitrogen) for 4 h. Thereafter, cells were stained with antibodies against surface markers, fixed, permeabilized using intracellular (IC) Fixation Buffer (eBioscience), and stained with anti-IL-5-APC (BioLegend), anti-IL-13-PerCP/Cy 5.5 (BioLegend), and anti-IL-10-PerCP/Cy 5.5 (BioLegend). The cells stained were examined with a FACSCanto II instrument (Becton Dickinson, Los Angeles, CA, USA). For data analysis, BD FlowJo software (BD Bioscience, version 10.9.0) was utilized.
+ Open protocol
+ Expand
2

Multicolor Flow Cytometry Analysis of Tumor-Infiltrating Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nine days after the treatment of MC38 tumours with indicated compounds, tumor infiltrating lymphocytes (TILs) were isolated and stained. For stimulation, cells were incubated with cell stimulation cocktail (PMA and Ionomycin) plus protein transport inhibitor (Brefeldin A and Menesin) for 4 hrs. Cells were analysed by multicolour flow cytometry (BD LSR Fortessa X-20). Antibodies: anti-CD45 BV605 (#103140, Biolegend); anti-CD3 BV875 (#100355, Biolegend); anti-CD4 BV650 (#100469, Biolegend); anti-CD8 (#100784, Biolegend); anti-FOXP3 PerCP-Cy5.5 (#563902, BD); anti-TNFα APC (#506308, Biolegend); anti-IFNγ FITC (#505806, Biolegend); anti-IL-2 BV510 (#503833, Biolegend); anti-IL10 PerCP-Cy5.5 (#505028, Biolegend). All analyses were performed using FlowJo_V10.6.1 software (Tree Star). Gating strategy: gate cells exclude dead cells and debris based on cells size, then gate live cells based on Live-Dead NIR negative cells, then gate CD45+ cells, then gate CD45+CD3+ cells, then gate CD45+CD3+CD8+ cells and CD45+CD3+CD4+ cells. Cytokine expression was determined in the populations of CD45+CD3+cells.
+ Open protocol
+ Expand
3

Multicolor Flow Cytometry Analysis of Tumor-Infiltrating Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nine days after the treatment of MC38 tumours with indicated compounds, tumor infiltrating lymphocytes (TILs) were isolated and stained. For stimulation, cells were incubated with cell stimulation cocktail (PMA and Ionomycin) plus protein transport inhibitor (Brefeldin A and Menesin) for 4 hrs. Cells were analysed by multicolour flow cytometry (BD LSR Fortessa X-20). Antibodies: anti-CD45 BV605 (#103140, Biolegend); anti-CD3 BV875 (#100355, Biolegend); anti-CD4 BV650 (#100469, Biolegend); anti-CD8 (#100784, Biolegend); anti-FOXP3 PerCP-Cy5.5 (#563902, BD); anti-TNFα APC (#506308, Biolegend); anti-IFNγ FITC (#505806, Biolegend); anti-IL-2 BV510 (#503833, Biolegend); anti-IL10 PerCP-Cy5.5 (#505028, Biolegend). All analyses were performed using FlowJo_V10.6.1 software (Tree Star). Gating strategy: gate cells exclude dead cells and debris based on cells size, then gate live cells based on Live-Dead NIR negative cells, then gate CD45+ cells, then gate CD45+CD3+ cells, then gate CD45+CD3+CD8+ cells and CD45+CD3+CD4+ cells. Cytokine expression was determined in the populations of CD45+CD3+cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!